EBF1 rs10952316: Blood Pressure Association & Genetics
The genetic variant rs10952316 is a single-nucleotide polymorphism located in the human EBF1 gene. Genome-wide association studies have identified it as a common trait-associated variant linked to small statistical variations in resting systolic and diastolic blood pressure levels. Because its measured effect size is modest and evidence strength is limited, it serves as a research marker rather than a diagnostic tool.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Carriers of the CC genotype have two copies of the C allele at this locus, representing the common baseline in many reference cohorts. In association studies, this genotype reflects standard population baseline trends for systolic and diastolic measurements. It confers neither dramatic protection nor elevated cardiovascular risk on its own. | Informational |
| CT | Individuals with the CT genotype carry one C allele and one T allele at this genomic site. In large GWAS cohorts, heterozygous individuals display intermediate, statistically subtle shifts in blood pressure measurements. Because the magnitude of this effect is negligible at the individual level, this genotype carries neutral biological significance. | Informational |
| TT | Carriers of the TT genotype have inherited two copies of the minor T allele at rs10952316. While population-level GWAS analyses link the minor allele with small statistical variations in resting blood pressure, it is not an independent cause of cardiovascular disease. Clinical outcomes depend overwhelmingly on lifestyle factors, polygenic background, and overall cardiovascular health. | Informational |
What is rs10952316 and Where is it Located?
The single-nucleotide polymorphism rs10952316 is a genomic point variation located on chromosome 5 in the human genome, situated within the region encoding early B-cell factor 1 (EBF1). Variants cataloged by resources like dbSNP represent locations where individuals commonly inherit different single base pairs of DNA. In the case of rs10952316, the alleles involve a substitution between cytosine (C) and thymine (T). As an intronic or non-coding variation, it does not alter an amino acid directly, but non-coding single-nucleotide changes can influence regulatory activity such as transcriptional efficiency, tissue-specific enhancers, or chromatin accessibility. Genome-wide mapping endeavors catalog rs10952316 among loci evaluated for cardiovascular and metabolic trait associations.
The Biological Role of the EBF1 Gene
The EBF1 gene codes for Early B-Cell Factor 1, a member of the COE (Collier/Olf/EBF) family of helix-loop-helix transcription factors. Although extensively studied for its essential role in orchestrating immune system development and committing precursor cells to the B-lymphocyte lineage, EBF1 is also broadly expressed in adipose tissue, kidneys, and vascular smooth muscle. Emerging experimental models indicate that EBF1 plays roles in perivascular differentiation, adipose tissue morphology, and arterial remodeling under vascular stress. Because blood pressure homeostasis involves intricate communication between vascular tone, renal filtering, and systemic inflammation, transcription factors like EBF1 that influence vascular architecture and cellular differentiation are plausible candidates in human cardiovascular genetics.
Research Findings and Evidence Strength
Genome-wide association studies (GWAS) analyzing hundreds of thousands of individuals have identified regions across the EBF1 gene locus as being associated with small differences in both systolic and diastolic blood pressure. According to curated genomics repositories including the GWAS Catalog, rs10952316 demonstrates a statistically significant population-level association with continuous blood pressure metrics. However, the scientific evidence supporting a direct causal role for this specific marker remains limited. Individual common variants identified via GWAS typically explain only tiny fractions of phenotypic variation—often corresponding to shifts of less than a single millimeter of mercury (mm Hg). It is also possible that rs10952316 is not the causal variant itself, but rather in linkage disequilibrium with other functional non-coding variants nearby.
Understanding Common Genotypes Across Populations
In global populations, rs10952316 is observed as a frequent polymorphism. Population reference datasets such as gnomAD and the 1000 Genomes Project report that the minor allele carries a frequency of approximately 0.30 (30%) among individuals of European ancestry. Because this allele is common, millions of people carry one or two copies without any single discernable clinical pathology. Allele distributions vary across continental groups, reflecting historical demographic patterns and genetic drift rather than differential survival pressures. Individuals can carry homozygous reference, heterozygous, or homozygous minor genotypes, each contributing marginally to an aggregate polygenic background rather than functioning as a deterministic switch for health conditions.
What You Can and Cannot Do with This Information
Understanding your rs10952316 genotype provides insight into your personal genome, but it cannot diagnose primary hypertension or guarantee healthy cardiovascular function. Blood pressure is an intricately polygenic trait shaped by hundreds of genetic variants working together with diet, physical activity, sodium intake, age, stress, and kidney health. Because the effect size of this individual variant is very small, possessing one or two copies of an associated allele does not warrant panic or targeted medical treatment. Genetic results should never replace standard clinical monitoring. If you have concerns about your blood pressure numbers, consulting a healthcare professional for regular cuff measurements and validated lifestyle strategies remains the standard of care.
How common is this variant?
The minor allele for rs10952316 occurs at an approximate frequency of 0.30 in populations of European ancestry, with common heterozygous and homozygous genotypes widely distributed across global cohorts.
Frequently asked questions
Does having the rs10952316 variant mean I will develop high blood pressure?
No, carrying an associated allele at rs10952316 does not mean you will develop hypertension. Blood pressure is influenced by hundreds of genetic loci alongside major lifestyle factors like diet, exercise, and stress, with rs10952316 contributing only a tiny fraction of total risk.
Can doctors prescribe blood pressure medication based on rs10952316?
No, clinical prescribing guidelines do not use rs10952316 to select or adjust antihypertensive therapy. Treatment decisions are based on physical blood pressure measurements, overall cardiovascular risk, and established clinical guidelines.
What role does the EBF1 gene play in the human body?
EBF1 encodes a transcription factor that is essential for B-cell immune development and plays additional roles in vascular smooth muscle differentiation, fat cell biology, and arterial tissue maintenance.
Why is the evidence for rs10952316 classified as limited?
While genome-wide studies show a statistically significant correlation with blood pressure metrics, the individual effect size is very subtle and functional laboratory validation proving direct causality for this specific SNP remains incomplete.
Sources & further reading
Educational information only, last refreshed 9/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10952316?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29